New treatment in breast cancer metastatic and pretreated

被引：0
作者：
Di Cristina, L
Cirrito, D
Vitello, S
机构：
[1] Serv Oncol, Alcamo, TP, Italy
[2] Osped S Elia Caltanissetta, Serv Oncol, Caltanissetta, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E26
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
[41]   Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients [J].
Freedman, Orit ;
Amir, Eitan ;
Dranitsaris, George ;
Napolskikh, Julie ;
Kumar, Ritu ;
Fralick, Michael ;
Chia, Stephen ;
Petrella, Teresa ;
Dent, Susan ;
Tonkin, Katia ;
Ahmad, Imran ;
Rayson, Daniel ;
Clemons, Mark .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) :377-383
[42]   ETOPOSIDE AND MITOMYCIN-C IN PRETREATED METASTATIC BREAST-CANCER [J].
MENICHETTI, ET ;
SILVA, RR ;
TUMMARELLO, D ;
MISERIA, S ;
TORRESI, U ;
CELLERINO, R .
TUMORI, 1989, 75 (05) :473-474
[43]   Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients [J].
Ellen B. Kossoff ;
Nuttapong Ngamphaiboon ;
Thomas J. Laudico ;
Tracey L. O’Connor .
Medical Oncology, 2011, 28 :115-120
[44]   Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients [J].
Orit Freedman ;
Eitan Amir ;
George Dranitsaris ;
Julie Napolskikh ;
Ritu Kumar ;
Michael Fralick ;
Stephen Chia ;
Teresa Petrella ;
Susan Dent ;
Katia Tonkin ;
Imran Ahmad ;
Daniel Rayson ;
Mark Clemons .
Breast Cancer Research and Treatment, 2009, 118 :377-383
[45]   Efficacy of the combination of irinotecan and bevacizumab in heavely pretreated metastatic breast cancer [J].
Espinos, J. ;
Olier-Garate, C. ;
Aramendia, J. M. ;
Fernandez Hidalgo, O. ;
Reyna, C. ;
De la Cruz, S. ;
del Barrio, A. ;
Garcia-Foncillas, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[46]   Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer [J].
Rha, SU ;
Moon, YH ;
Jeung, HC ;
Kim, YT ;
Sohn, JH ;
Yang, WI ;
Suh, CO ;
Kim, GE ;
Roh, JK ;
Chung, HC .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) :215-221
[47]   Trastuzumab (herceptin™) monotherapy in patients with pretreated metastatic breast cancer. [J].
Eidtmann, H ;
Clemens, M ;
von Minckwitz, G ;
Nitz, U ;
Marme, A ;
Niederle, N ;
du Bois, A ;
Habicht, A .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) :303-303
[48]   Daily oral etoposide in patients with heavily pretreated metastatic breast cancer [J].
Pusztai, L ;
Walters, RS ;
Valero, V ;
Theriault, RL ;
Hortobagyi, GN .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (05) :442-446
[49]   Lonsurf® - A new Option for Patients with pretreated metastatic Gastric Cancer [J].
VISCERAL MEDICINE, 2019, 35 (06) :401-401
[50]   Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer [J].
Zambelli, A ;
della Cuna, FSR ;
Ponchio, L ;
Ucci, G ;
Da Prada, GA ;
della Cuna, GR .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 61 (03) :241-247
12345